Cite
Data from A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo
MLA
Jonathan A. Pachter, et al. Data from A Novel, Potent, and Selective Insulin-like Growth Factor-I Receptor Kinase Inhibitor Blocks Insulin-like Growth Factor-I Receptor Signaling in Vitro and Inhibits Insulin-like Growth Factor-I Receptor–dependent Tumor Growth in Vivo. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....14c6d78e18d5213a54ae84ba8a5326f5&authtype=sso&custid=ns315887.
APA
Jonathan A. Pachter, Neil W. Gibson, Lee D. Arnold, Alexandra Eyzaguirre, Elizabeth Buck, Caroline Pirritt, Yan Yao, Matthew O’Connor, Gilda Mak, Lixin Feng, Andrew Cooke, Maryland Rosenfeld-Franklin, Mark J. Mulvihill, & Qun-sheng Ji. (2023). Data from A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo.
Chicago
Jonathan A. Pachter, Neil W. Gibson, Lee D. Arnold, Alexandra Eyzaguirre, Elizabeth Buck, Caroline Pirritt, Yan Yao, et al. 2023. “Data from A Novel, Potent, and Selective Insulin-like Growth Factor-I Receptor Kinase Inhibitor Blocks Insulin-like Growth Factor-I Receptor Signaling in Vitro and Inhibits Insulin-like Growth Factor-I Receptor–dependent Tumor Growth in Vivo,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....14c6d78e18d5213a54ae84ba8a5326f5&authtype=sso&custid=ns315887.